NO20024959L - Polyamidnukleinsyrederivater, midler og fremgangsmÕter for deres fremstilling - Google Patents

Polyamidnukleinsyrederivater, midler og fremgangsmÕter for deres fremstilling

Info

Publication number
NO20024959L
NO20024959L NO20024959A NO20024959A NO20024959L NO 20024959 L NO20024959 L NO 20024959L NO 20024959 A NO20024959 A NO 20024959A NO 20024959 A NO20024959 A NO 20024959A NO 20024959 L NO20024959 L NO 20024959L
Authority
NO
Norway
Prior art keywords
agents
processes
preparation
nucleic acid
acid derivatives
Prior art date
Application number
NO20024959A
Other languages
English (en)
Other versions
NO20024959D0 (no
NO333193B1 (no
Inventor
Eugen Uhlmann
Gerhard Breipohl
David William Will
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20024959D0 publication Critical patent/NO20024959D0/no
Publication of NO20024959L publication Critical patent/NO20024959L/no
Publication of NO333193B1 publication Critical patent/NO333193B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
NO20024959A 2000-04-18 2002-10-15 Polyamidnukleinsyrederivater, anvendelse derav, midler inneholdende PNAderivatet og fremgangsmater for deres fremstilling. NO333193B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10019135A DE10019135A1 (de) 2000-04-18 2000-04-18 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
PCT/EP2001/004030 WO2001079216A2 (de) 2000-04-18 2001-04-07 Polyamidnukleinsäure-derivate, mittel und verfahren zur ihrer herstellung

Publications (3)

Publication Number Publication Date
NO20024959D0 NO20024959D0 (no) 2002-10-15
NO20024959L true NO20024959L (no) 2002-10-15
NO333193B1 NO333193B1 (no) 2013-04-02

Family

ID=7639143

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024959A NO333193B1 (no) 2000-04-18 2002-10-15 Polyamidnukleinsyrederivater, anvendelse derav, midler inneholdende PNAderivatet og fremgangsmater for deres fremstilling.

Country Status (21)

Country Link
US (5) US6905820B2 (no)
EP (1) EP1276760B1 (no)
JP (1) JP4908714B2 (no)
KR (1) KR100842723B1 (no)
AR (1) AR032153A1 (no)
AT (1) ATE344276T1 (no)
AU (1) AU5479501A (no)
BR (1) BR0110110A (no)
CA (1) CA2406169C (no)
CY (1) CY1105958T1 (no)
DE (2) DE10019135A1 (no)
DK (1) DK1276760T3 (no)
ES (1) ES2275677T3 (no)
IL (2) IL152288A0 (no)
MX (1) MXPA02009953A (no)
NO (1) NO333193B1 (no)
NZ (1) NZ521988A (no)
PT (1) PT1276760E (no)
TW (1) TWI298328B (no)
WO (1) WO2001079216A2 (no)
ZA (1) ZA200208344B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518017B1 (en) * 1997-10-02 2003-02-11 Oasis Biosciences Incorporated Combinatorial antisense library
US20030165888A1 (en) 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
JP2003517283A (ja) * 1999-04-08 2003-05-27 オアシス バイオサイエンシーズ インコーポレイティッド プライマーペアの増幅及び配列決定並びにそれらの使用
DE10019135A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
TWI286849B (en) * 2003-03-25 2007-09-11 Nichia Corp Positive electrode active material for nonaqueous electrolyte secondary battery and nonaqueous electrolyte secondary battery
JP2010528615A (ja) * 2007-05-31 2010-08-26 サノフィ−アベンティス ＮＡＰＥ−ＰＬＤ又はＡｂｈ４の活性を修飾する薬剤を同定するためのアッセイ方法
WO2009044403A2 (en) * 2007-10-05 2009-04-09 Juvenis Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
US20090276855A1 (en) * 2008-04-30 2009-11-05 Nokia Corporation Method, apparatus, and computer program product that provide for presentation of event items
US20090276436A1 (en) * 2008-04-30 2009-11-05 Nokia Corporation Method, apparatus, and computer program product for providing service invitations
US20090276412A1 (en) * 2008-04-30 2009-11-05 Nokia Corporation Method, apparatus, and computer program product for providing usage analysis
US20090276700A1 (en) * 2008-04-30 2009-11-05 Nokia Corporation Method, apparatus, and computer program product for determining user status indicators
US20090292762A1 (en) * 2008-05-20 2009-11-26 Nokia Corporation Method, Apparatus, and Computer Program Product for Publishing Content
US20090327434A1 (en) * 2008-06-30 2009-12-31 Nokia Corporation Method, Apparatus, and Computer Program Product for Anonymous Polling
JP5990987B2 (ja) * 2012-04-11 2016-09-14 株式会社Ihi 微生物固定方法、および微生物検出方法
JP2015172904A (ja) * 2014-03-12 2015-10-01 株式会社東芝 Ｌｄｏ型電圧レギュレータ、及び、受電装置
US20180030065A1 (en) * 2015-01-27 2018-02-01 Isi Life Sciences, Inc. Fluorescein polymer conjugates
KR102659194B1 (ko) * 2016-07-26 2024-04-19 삼성전자주식회사 홀로그래픽 디스플레이 장치용 박형 백라이트 유닛 및 이를 포함하는 홀로그래픽 디스플레이 장치

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0972779A3 (en) * 1987-10-28 2004-10-20 Howard Florey Institute Of Experimental Physiology And Medicine Oligonucleotide-polyamide conjugates
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
DE699079T1 (de) * 1994-03-07 1997-09-25 Dendritech Inc Bioaktive und/oder gezielte dendrimere-konjugate
DE4408528A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Peptid-Oligonucleotid-Derivate, deren Herstellung und Verwendung
DE4408531A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
EP0804456B1 (en) * 1994-10-06 2002-08-21 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
DE19508923A1 (de) * 1995-03-13 1996-09-19 Hoechst Ag Phosphonomonoesternukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0739898B1 (de) * 1995-03-13 2001-09-26 Aventis Pharma Deutschland GmbH Phosphonomonoesternnukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19640974A1 (de) * 1996-10-04 1998-04-16 Bayer Ag Bausteine für DNA/PNA-Cooligomere
DE19757516A1 (de) * 1997-12-23 1999-06-24 Roche Diagnostics Gmbh Modifizierte Nukleinsäureanaloga
US6326479B1 (en) * 1998-01-27 2001-12-04 Boston Probes, Inc. Synthetic polymers and methods, kits or compositions for modulating the solubility of same
US6043352A (en) * 1998-08-07 2000-03-28 Isis Pharmaceuticals, Inc. 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
DE10019135A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
DE10019136A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
PT1276760E (pt) 2007-02-28
NO20024959D0 (no) 2002-10-15
JP4908714B2 (ja) 2012-04-04
CA2406169A1 (en) 2001-10-25
NZ521988A (en) 2004-12-24
JP2004501211A (ja) 2004-01-15
DE50111371D1 (de) 2006-12-14
AU5479501A (en) 2001-10-30
AR032153A1 (es) 2003-10-29
BR0110110A (pt) 2003-02-11
IL152288A (en) 2010-11-30
MXPA02009953A (es) 2003-02-12
EP1276760A2 (de) 2003-01-22
US20110117569A1 (en) 2011-05-19
ES2275677T3 (es) 2007-06-16
TWI298328B (en) 2008-07-01
DE10019135A1 (de) 2001-10-31
CY1105958T1 (el) 2011-04-06
CA2406169C (en) 2012-06-19
US7897346B2 (en) 2011-03-01
ATE344276T1 (de) 2006-11-15
IL152288A0 (en) 2003-05-29
US7550582B2 (en) 2009-06-23
KR20030036166A (ko) 2003-05-09
ZA200208344B (en) 2003-08-21
US20080070258A1 (en) 2008-03-20
WO2001079216A2 (de) 2001-10-25
US20020187473A1 (en) 2002-12-12
WO2001079216A3 (de) 2002-02-28
KR100842723B1 (ko) 2008-07-01
EP1276760B1 (de) 2006-11-02
NO333193B1 (no) 2013-04-02
US8268560B2 (en) 2012-09-18
DK1276760T3 (da) 2007-03-19
US20100022016A1 (en) 2010-01-28
US20050009073A1 (en) 2005-01-13
US6905820B2 (en) 2005-06-14

Similar Documents

Publication Publication Date Title
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20034751D0 (no) Antranilsyreamider, deres fremstilling og anvendelse samt preparater
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20024959D0 (no) Polyamidnukleinsyrederivater, midler og fremgangsmåter for deres fremstilling
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20040210L (no) Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler
DK1282639T3 (da) Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf
NO20025542D0 (no) Kinolonkarboksylsyrederivater
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20030375D0 (no) N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater
NO20033965L (no) Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1404663T3 (da) Eurotinoner og derivater deraf, fremgangsmåde til deres fremstilling og anvendelse heraf
NO20020404D0 (no) Streptograminderivater, deres produksjon og forbindelser derav
NO20023845D0 (no) Pluraflaviner og derivater derav, fremgangsmåte for fremstilling av disse og deres anvendelse
NO20011921L (no) Sulfidoamidokarboksylsyre, deres fremstilling og anvendelse
FI20000395A (fi) N-(amidinobentsoyyli- tai amidinopyridyylikarbonyyli)-alfa-aminohappojohdannaisia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees